Veloxity Labs: an interview with Shane Needham and Mitch Johnson

Automation Drug development Interviews MS (LC–MS/MS, HRMS, IMS)

In this interview Shane Needham (Co-founder, CEO and President of Veloxity Labs; ID, USA) and Mitch Johnson (Co-founder and Laboratory Director of Veloxity Labs; IL, USA) discuss key events and developments that led to them founding the new company. They address what Veloxity Labs specializes in and important elements that they find the most rewarding. Whilst sharing their vast industry experience they also highlight what they hope Veloxity Labs will bring to the bioanalytical community.

Questions discussed:

    1. What led to you founding Veloxity Labs?
    2. What does Veloxity Labs specialize in?
    3. What elements of being part of a CRO do you find the most rewarding?
    4. What do you hope Veloxity Labs will bring to the bioanalytical community?

About the speakers:

Shane Needham

Dr Needham is founder, President and CEO of Veloxity Labs. Veloxity Labs is a bioanalytical CRO focused on LC−MS with the founders having more than 100 years of experience and a unique structure of employee owned and operated. Dr Needham has more than 30 years-experience in LC−MS bioanalysis. He is known as a resident expert in bioanalysis and has over 200 publications in the area. Dr Needham is a serial entrepreneur for scientific businesses including CRO’s. His businesses have a return on investment of >70,000% over 20 years. His CRO’s have been listed as a fastest growing company by INC 5000. Under his direction his labs have led the industry in dried blood spot analysis, microflow LC−MS/MS and small and large molecule (ADC’s, biomarkers, oligonucleotides, mAbs, et al.) bioanalysis.

Shane is also a wrestling coach, national champion bodybuilder, state champion powerlifter and Ted Talk speaker. Shane has four children and considers them his biggest accomplishment.

 

Mitch Johnson

Mitch earned a bachelor’s degree in chemistry from Monmouth College (IL, USA) and a PhD in analytical chemistry from the University of Missouri (MO, USA). His dissertation work was primarily focused on LC−MS/MS for metabolomics analysis of agricultural products. Since 2017, he has held senior level bioanalytical and DMPK laboratory positions within the pharmaceutical CRO industry.

 

In association with